A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
Clinical trial NCT00094926 · COMPLETED
Trial details
- NCT number
- NCT00094926
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.